High-fat diet (HFD)-induced dyslipidemia is frequently accompanied by gut microbiota dysbiosis and compromised gut barrier. Enhancing intestinal barrier function emerges as a potential therapeutic approach for dyslipidemia. The ILC3-IL22-IL-22R pathway,...